December 2021, Dr. Kristi Kelley

December 13, 2021

PDF icon Spill the 5-HTea: Pharmacologic Considerations in the Treatment of Major Depressive Disorder Program Packet

In the Baptist Health Foundation Center for Medical and Surgical Care at Princeton Baptist Medical Center, a high proportion of patients receive treatment for major depressive disorder. The ambulatory care staff, including nurses, attending and resident physicians, pharmacists, and social workers collaborate as a team to best manage patients with chronic mental health disorders, including depression. Current guidelines for depression state that a disconnect between the patient, provider, and their current therapies can lead to diminished treatment success. Therefore, it is important that all healthcare professionals involved in the treatment of depression have a working knowledge of patient-specific goals and the interventions being provided.

On a daily basis, the treatment of depression is frequently discussed among the clinic team, including appropriate product selection and dosing of antidepressants. Since there are multiple mental health disorders, medication classes, and multimodal approaches to treatment, the primary objective of this presentation will be to increase the staff’s knowledge on the role of different pharmacological treatment options for patients with major depressive disorder. The following points will be discussed: the pathophysiology of depression, screening and diagnosis, medication mechanisms of action, administration, side effects, monitoring considerations, and resources to assist in the long-term management of the disease.

Lauren Campisi and Luke Hentrich, fourth-year pharmacy students at the Auburn University Harrison School of Pharmacy, will be assisting with the development and delivery of this program.

 

Target Audience

Nurses and Nurse Practicioners

Learning Objectives

  1. Outline the guideline-recommended treatment options for depression.
  2. Compare and contrast the prescription drug classes used for the treatment of depression.
  3. Discuss the role of over-the-counter products and non-pharmacologic interventions for the treatment of depression.
  4. Review helpful resources for patients with depression and their providers.
Course summary
Available credit: 
  • 1.20 ABN
    Auburn University Harrison School of Pharmacy is a Board approved provider of continuing nursing education in Alabama by the Alabama Board of Nursing. Provider Number: ABNP1515
Course opens: 
09/14/2021
Course expires: 
12/30/2022
Event starts: 
12/13/2021 - 10:00am
Event ends: 
12/13/2021 - 11:00am
Cost:
$0.00
Rating: 
0

PDF icon SPILL THE 5-HTEA: PHARMACOLOGIC CONSIDERATIONS IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER

Outline:

  • Epidemiology of depression
  • Pathophysiology, with a focus on the neurotransmitter hypothesis
  • Screening and diagnosis
  • Treatment algorithm with guideline-recommended options
  • Comparison of antidepressants with pharmacologic pearls
  • Over-the-counter products for depression
  • Non-pharmacologic interventions
  • Helpful resources for patients and providers

Faculty: Kristi Kelley

 

 

 

Available Credit

  • 1.20 ABN
    Auburn University Harrison School of Pharmacy is a Board approved provider of continuing nursing education in Alabama by the Alabama Board of Nursing. Provider Number: ABNP1515

Price

Cost:
$0.00
Please login or register to take this course.

Please click REGISTER/TAKE COURSE to proceed.